Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Group

Université du Québec à Montréal

$33,000.00

Characterization of interaction partners of HIV and MuL V integrases

FY 2010-11

Summary
Although the basic mechanism of retroviral integration was resolved and although the necessity of the viral integrase in this process was clearly demonstrated, the contribution of the host in this process is not clearly defined. Several cofactors of the retroviral integrase were identified by various methods, but questions remain as for the efficiency of the integration, the integration site selection and the in vivo inhibition of the reverse reaction of the integration, the disintegration. Furthermore, the differences observed between retrovirus during this process, notably as regards the selection of the sites of integration of the viral genome in the genome of the host, suggest the intervention of cellular cofactors specific of the virus. Our short-term purpose is the identification and the characterization of new cellular partners of the integrases of the virus of the human immunodeficiency of type 1, and of Graffi and Cas-Br-E murine leukemia viruses. Our long-term goal is to clarify the mechanism of integration, to bring to light differences at the level of the interaction of the integrase with host proteins according to the virus and to answer the remaining questions. The knowledge of the interactions between the host and the virus during the process of integration should create not only new tools for gene studies (targeting of gene) but also new developments in engineering, particularly in the field of gene therapy based on the use of retroviral vectors. Indeed, the possibility of targeting exactly specific regions of the host genome should contribute to increase the efficiency of these approaches and to eliminate the risk of the cancer due to insertional mutagenesis. Furthermore, this should have a major impact in the field of antiviral therapies by offering a tremendous platform for the selection of new antiviral targets and for the elaboration of new drugs against retroviral infections.
Program
Discovery Grants Program - Group
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
371520-2010
Name nom
Rassart, Eric
Department département
Sciences biologiques
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
33000
Program id
RGPGP
Program name en
Discovery Grants Program - Group
Program name fr
Programme de subventions à la découverte - équipe
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Protein manipulation and expression
Research subject fr
Expression et recombinaison protéiques
Partie
1
Nb partie
5
Application title
Characterization of interaction partners of HIV and MuL V integrases
Keyword
NSERC
Application summary
Although the basic mechanism of retroviral integration was resolved and although the necessity of the viral integrase in this process was clearly demonstrated, the contribution of the host in this process is not clearly defined. Several cofactors of the retroviral integrase were identified by various methods, but questions remain as for the efficiency of the integration, the integration site selection and the in vivo inhibition of the reverse reaction of the integration, the disintegration. Furthermore, the differences observed between retrovirus during this process, notably as regards the selection of the sites of integration of the viral genome in the genome of the host, suggest the intervention of cellular cofactors specific of the virus. Our short-term purpose is the identification and the characterization of new cellular partners of the integrases of the virus of the human immunodeficiency of type 1, and of Graffi and Cas-Br-E murine leukemia viruses. Our long-term goal is to clarify the mechanism of integration, to bring to light differences at the level of the interaction of the integrase with host proteins according to the virus and to answer the remaining questions. The knowledge of the interactions between the host and the virus during the process of integration should create not only new tools for gene studies (targeting of gene) but also new developments in engineering, particularly in the field of gene therapy based on the use of retroviral vectors. Indeed, the possibility of targeting exactly specific regions of the host genome should contribute to increase the efficiency of these approaches and to eliminate the risk of the cancer due to insertional mutagenesis. Furthermore, this should have a major impact in the field of antiviral therapies by offering a tremendous platform for the selection of new antiviral targets and for the elaboration of new drugs against retroviral infections.
Université du Québec à Montréal - $33,000 Grant (2010… | Canada Spends